MedPath

石药集团欧意药业有限公司

Ownership
-
Established
2001-03-29
Employees
-
Market Cap
-
Website
https://www.e-cspc.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

648

NMPA:648

Drug Approvals

Cobamamide Capsules

Product Name
腺苷钴胺胶囊
Approval Number
国药准字H20254373
Approval Date
May 27, 2025
NMPA

Diprophylline Injection

Product Name
二羟丙茶碱注射液
Approval Number
国药准字H20258092
Approval Date
May 26, 2025
NMPA

Aminophylline Injection

Product Name
氨茶碱注射液
Approval Number
国药准字H20258078
Approval Date
May 9, 2025
NMPA

Vonoprazan Fumarate Tablets

Product Name
富马酸伏诺拉生片
Approval Number
国药准字H20254041
Approval Date
Apr 30, 2025
NMPA

Vonoprazan Fumarate Tablets

Product Name
富马酸伏诺拉生片
Approval Number
国药准字H20254042
Approval Date
Apr 30, 2025
NMPA

Regorafenib Tablets

Product Name
瑞戈非尼片
Approval Number
国药准字H20253178
Approval Date
Jan 14, 2025
NMPA

Prusogliptin Tablets

Product Name
善泽平
Approval Number
国药准字H20250001
Approval Date
Jan 8, 2025
NMPA

Palbociclib Tablets

Product Name
哌柏西利片
Approval Number
国药准字H20249515
Approval Date
Dec 1, 2024
NMPA

Palbociclib Tablets

Product Name
哌柏西利片
Approval Number
国药准字H20244133
Approval Date
Nov 27, 2024
NMPA

Dexrazoxane for Injection

Product Name
注射用右雷佐生
Approval Number
国药准字H20244665
Approval Date
Aug 20, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 65
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.